Showing 521 - 540 results of 41,690 for search '(( a point decrease ) OR ( 50 ((((ns decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.13s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529
  10. 530

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  11. 531

    MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

    Published 2014
    “…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”
  12. 532
  13. 533
  14. 534
  15. 535

    Disrupting actin stress fibers decreases [Ca<sup>2+</sup>]<sub>i</sub> oscillation frequency. by Charles Godbout (540424)

    Published 2013
    “…D) [Ca<sup>2+</sup>]<sub>i</sub> oscillation period was calculated before Cytochalasin D treatment and plotted against the period after treatment for the same cell. Any point above the diagonal indicates a period decrease after addition of the drug (n<sub>exp = </sub>9, n<sub>cells</sub> = 25).…”
  16. 536
  17. 537

    Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

    Published 2025
    “…This study aimed to derive benchmark concentrations from RNaseq data (transcriptomic points-of-departure; tPOD) from a short-term exposure study with early life stages of rainbow trout (RBT; Oncorhynchus mykiss) using benzo[<i>a</i>]pyrene (B[<i>a</i>]P) as the model compound. tPODs were then calibrated with higher organizational-level responses observed during an extended 28 day exposure period. …”
  18. 538

    Rac1 activity decreases in the presence of DECMA-1 and E-cadherin:Fc in 3-D cell aggregates. by Khameeka N. Kitt (227731)

    Published 2011
    “…<p>3-D MDCK cell aggregates were incubated with 10 µg/ml of DECMA-1 monovalent Fab' fragments (A), or 10 µg/ml of purified E-cadherin:Fc extracellular domain (E), or 10 µg/ml of Fc protein (I) for the indicated times. …”
  19. 539
  20. 540